Trial Profile
Phase 1 safety, tolerability, and pharmacokinetic study of Docetaxel nano-dispersion: A randomized, open label, dose ranging, active controlled, comparative, parallel groups, and multi-centric study.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Breast cancer; Non-small cell lung cancer; Prostate cancer; Tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sun Pharma Advanced Research Company
- 17 Sep 2010 New trial record